<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	>
<channel>
	<title>Comments on: LDN Research Trust Mailing</title>
	<atom:link href="http://glasgowldn2009.com/2009/02/ldn-research-trust-mailing/feed/" rel="self" type="application/rss+xml" />
	<link>http://glasgowldn2009.com/2009/02/ldn-research-trust-mailing/</link>
	<description>The first European Low Dose Naltrexone Conference, Glasgow University, 25th April, 2009</description>
	<pubDate>Sat, 04 Feb 2012 20:41:33 +0000</pubDate>
	<generator>http://wordpress.org/?v=2.6.5</generator>
		<item>
		<title>By: Tom Gilhooly</title>
		<link>http://glasgowldn2009.com/2009/02/ldn-research-trust-mailing/#comment-771</link>
		<dc:creator>Tom Gilhooly</dc:creator>
		<pubDate>Thu, 16 Apr 2009 16:07:09 +0000</pubDate>
		<guid isPermaLink="false">http://glasgowldn2009.com/?p=120#comment-771</guid>
		<description>Lisa,
       the conference will be filmed and published online both in you tube and on the conference web site. 

Dr Tom Gilhooly</description>
		<content:encoded><![CDATA[<p>Lisa,<br />
       the conference will be filmed and published online both in you tube and on the conference web site. </p>
<p>Dr Tom Gilhooly</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Dr.Atsuo Yanagisawa</title>
		<link>http://glasgowldn2009.com/2009/02/ldn-research-trust-mailing/#comment-406</link>
		<dc:creator>Dr.Atsuo Yanagisawa</dc:creator>
		<pubDate>Sun, 05 Apr 2009 11:12:03 +0000</pubDate>
		<guid isPermaLink="false">http://glasgowldn2009.com/?p=120#comment-406</guid>
		<description>Hello,
 In Japan, only 3 physicians practice LDN and all of them started in 2009 at this time. From February 2009, I started LDN therapy for 2 patients with Parkinson disease, one with ALS, and 10 with cancer. I will attend this conference and learn lots of LDN therapy from the expert. I am happy to see everybody in Glasgow.

Warm regards,

Atsuo Yanagisawa, M.D.
President
10th International Congress of Integrative Medicine 2009 in Japan.</description>
		<content:encoded><![CDATA[<p>Hello,<br />
 In Japan, only 3 physicians practice LDN and all of them started in 2009 at this time. From February 2009, I started LDN therapy for 2 patients with Parkinson disease, one with ALS, and 10 with cancer. I will attend this conference and learn lots of LDN therapy from the expert. I am happy to see everybody in Glasgow.</p>
<p>Warm regards,</p>
<p>Atsuo Yanagisawa, M.D.<br />
President<br />
10th International Congress of Integrative Medicine 2009 in Japan.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Lisa Clapp</title>
		<link>http://glasgowldn2009.com/2009/02/ldn-research-trust-mailing/#comment-313</link>
		<dc:creator>Lisa Clapp</dc:creator>
		<pubDate>Tue, 31 Mar 2009 09:59:52 +0000</pubDate>
		<guid isPermaLink="false">http://glasgowldn2009.com/?p=120#comment-313</guid>
		<description>Please can you tell me if the conference presentations and notes will definately be online as I won't be able to attend.  Many thanks
Lisa</description>
		<content:encoded><![CDATA[<p>Please can you tell me if the conference presentations and notes will definately be online as I won&#8217;t be able to attend.  Many thanks<br />
Lisa</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Kim Sahiri</title>
		<link>http://glasgowldn2009.com/2009/02/ldn-research-trust-mailing/#comment-172</link>
		<dc:creator>Kim Sahiri</dc:creator>
		<pubDate>Mon, 16 Mar 2009 13:20:27 +0000</pubDate>
		<guid isPermaLink="false">http://glasgowldn2009.com/?p=120#comment-172</guid>
		<description>Hi there,
I am extremely exited at the prospect of taking L.D.N. and the hope it may offer so many of us. I need to have your help in one area please, I have M.S. with seizures and I have spent days trying to find if there are any contra-indications between anticonvulsants and low dose Naltrexone? I cannot find anything to suugest that there is, and in some studies it actually benefited the ant-convulsant, would you possibly give me some advice regarding this please?
Thanking You,
Kim</description>
		<content:encoded><![CDATA[<p>Hi there,<br />
I am extremely exited at the prospect of taking L.D.N. and the hope it may offer so many of us. I need to have your help in one area please, I have M.S. with seizures and I have spent days trying to find if there are any contra-indications between anticonvulsants and low dose Naltrexone? I cannot find anything to suugest that there is, and in some studies it actually benefited the ant-convulsant, would you possibly give me some advice regarding this please?<br />
Thanking You,<br />
Kim</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Brendan Quinn</title>
		<link>http://glasgowldn2009.com/2009/02/ldn-research-trust-mailing/#comment-101</link>
		<dc:creator>Brendan Quinn</dc:creator>
		<pubDate>Fri, 06 Mar 2009 13:16:48 +0000</pubDate>
		<guid isPermaLink="false">http://glasgowldn2009.com/?p=120#comment-101</guid>
		<description>Hello Tom, I've been making LDN in-house in my Irish Pharmacy for years..myself and a colleague are trying to get a licence to permit distribution throughout the EU; there are barriers, but none insurmountable; the drug is now very stricly controlled in the US, and we had to get special licence to obtain it in pure form, as it is classified as a "biohazard" !
If I can be of help, my email is bqpharm@gmail.com
Brendan Quinn, Gort, Co Galway. Hope to see you at the conference!</description>
		<content:encoded><![CDATA[<p>Hello Tom, I&#8217;ve been making LDN in-house in my Irish Pharmacy for years..myself and a colleague are trying to get a licence to permit distribution throughout the EU; there are barriers, but none insurmountable; the drug is now very stricly controlled in the US, and we had to get special licence to obtain it in pure form, as it is classified as a &#8220;biohazard&#8221; !<br />
If I can be of help, my email is <a href="mailto:bqpharm@gmail.com">bqpharm@gmail.com</a><br />
Brendan Quinn, Gort, Co Galway. Hope to see you at the conference!</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Janak</title>
		<link>http://glasgowldn2009.com/2009/02/ldn-research-trust-mailing/#comment-84</link>
		<dc:creator>Janak</dc:creator>
		<pubDate>Tue, 03 Mar 2009 11:45:07 +0000</pubDate>
		<guid isPermaLink="false">http://glasgowldn2009.com/?p=120#comment-84</guid>
		<description>It would be great to have the presentation and the slides online. As I unfortunately am unable to attend.</description>
		<content:encoded><![CDATA[<p>It would be great to have the presentation and the slides online. As I unfortunately am unable to attend.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Gillian Goldberg</title>
		<link>http://glasgowldn2009.com/2009/02/ldn-research-trust-mailing/#comment-57</link>
		<dc:creator>Gillian Goldberg</dc:creator>
		<pubDate>Thu, 26 Feb 2009 08:43:50 +0000</pubDate>
		<guid isPermaLink="false">http://glasgowldn2009.com/?p=120#comment-57</guid>
		<description>Think I might have done something wrong when sending a comment in.  Would you be kind enough, please, to let me know whether you did in fact receive it?  Thanks -</description>
		<content:encoded><![CDATA[<p>Think I might have done something wrong when sending a comment in.  Would you be kind enough, please, to let me know whether you did in fact receive it?  Thanks -</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Gillian Goldberg</title>
		<link>http://glasgowldn2009.com/2009/02/ldn-research-trust-mailing/#comment-56</link>
		<dc:creator>Gillian Goldberg</dc:creator>
		<pubDate>Thu, 26 Feb 2009 08:41:47 +0000</pubDate>
		<guid isPermaLink="false">http://glasgowldn2009.com/?p=120#comment-56</guid>
		<description>LDN is hugely exciting.  My husband Paul is an MS patient, diagnosed at 28, now 68, relapsing-remitting until approx. 18 months ago, now primary progressive.  Has had pretty rare relapses.  A circuitous and synchronistic cycle of events led us to Bob Lawrence - who was astonished that although Paul has had walking problems for quite a while due to issues with balance, since he had an FES for his foot drop for around a year, he doesn't even use a walking stick - or need one!  He's going to be starting on Bob's LDN programme shortly.  We're both thrilled at the potential for LDN and I, having a great deal more time to spare than Paul - who works a 6-hour day away from home during the week - have been doing much research and spreading the word when I can.  Wish we could attend the Conference, but finances prevent that;  however, we'll be looking out for the info on the web.  Meantime, with all our very best wishes for Glasgow, and a very speedy acceptance of this treatment by the whole of the NHS.  Gillian Goldberg</description>
		<content:encoded><![CDATA[<p>LDN is hugely exciting.  My husband Paul is an MS patient, diagnosed at 28, now 68, relapsing-remitting until approx. 18 months ago, now primary progressive.  Has had pretty rare relapses.  A circuitous and synchronistic cycle of events led us to Bob Lawrence - who was astonished that although Paul has had walking problems for quite a while due to issues with balance, since he had an FES for his foot drop for around a year, he doesn&#8217;t even use a walking stick - or need one!  He&#8217;s going to be starting on Bob&#8217;s LDN programme shortly.  We&#8217;re both thrilled at the potential for LDN and I, having a great deal more time to spare than Paul - who works a 6-hour day away from home during the week - have been doing much research and spreading the word when I can.  Wish we could attend the Conference, but finances prevent that;  however, we&#8217;ll be looking out for the info on the web.  Meantime, with all our very best wishes for Glasgow, and a very speedy acceptance of this treatment by the whole of the NHS.  Gillian Goldberg</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Dr Tom Gilhooly</title>
		<link>http://glasgowldn2009.com/2009/02/ldn-research-trust-mailing/#comment-32</link>
		<dc:creator>Dr Tom Gilhooly</dc:creator>
		<pubDate>Sun, 22 Feb 2009 09:18:52 +0000</pubDate>
		<guid isPermaLink="false">http://glasgowldn2009.com/?p=120#comment-32</guid>
		<description>Dawn,
         at the conference I will outline the research on LDN to date. There are four studies of note on LDN and MS. If you cannot attend the actual conference we will arrange to have the presentations and the slides online. As a practitioner who has used this for the past five years on hundreds of MS patients, I am very impressed by the results we have seen. I plan to start a research project later this year on LDN and MS.</description>
		<content:encoded><![CDATA[<p>Dawn,<br />
         at the conference I will outline the research on LDN to date. There are four studies of note on LDN and MS. If you cannot attend the actual conference we will arrange to have the presentations and the slides online. As a practitioner who has used this for the past five years on hundreds of MS patients, I am very impressed by the results we have seen. I plan to start a research project later this year on LDN and MS.</p>
]]></content:encoded>
	</item>
	<item>
		<title>By: Dawn Ashby</title>
		<link>http://glasgowldn2009.com/2009/02/ldn-research-trust-mailing/#comment-18</link>
		<dc:creator>Dawn Ashby</dc:creator>
		<pubDate>Tue, 17 Feb 2009 14:01:51 +0000</pubDate>
		<guid isPermaLink="false">http://glasgowldn2009.com/?p=120#comment-18</guid>
		<description>I am interested in learning more about this amazing product to treat my MS.</description>
		<content:encoded><![CDATA[<p>I am interested in learning more about this amazing product to treat my MS.</p>
]]></content:encoded>
	</item>
</channel>
</rss>

